We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Reimbursement for Unproven Therapies: The Case of Thermography

Thomas C. LaBorde, MD
JAMA. 1993;270(21):2558. doi:10.1001/jama.1993.03510210044019.
Text Size: A A A
Published online


To the Editor.  —I feel compelled to comment on the misrepresentations and misinformation included in the article entitled "Court-Ordered Reimbursement for Unproven Medical Technology: Circumventing Technology Assessment" by Ferguson et al.1 More important, the lThermography is likened to Laetrile (amygdalin) and immunoaugmentive therapy as having "been assessed as not safe, not effective, or inadequately evaluated." Yet, thermography has been declared safe by the Food and Drug Administration (Victor Zafra, written communication, March 12,1982), considered as useful by the American Medical Association Council on Scientific Affairs2 in the evaluation of certain neuromusculoskeletal conditions, and effective by the American Academy of Physical Medicine and Rehabilitation3 in the evaluation of reflex sympathetic dystrophy. In contrast, similar support for Laetrile and immunoaugmentive therapy by organizations does not exist. Ferguson et al create the false perception that thermography is some type of unproven, fringe technology when in fact it is not.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.